277 related articles for article (PubMed ID: 31831256)
1. The immunobiology of mTOR in autoimmunity.
Suto T; Karonitsch T
J Autoimmun; 2020 Jun; 110():102373. PubMed ID: 31831256
[TBL] [Abstract][Full Text] [Related]
2. Natural Killer Cells: Potential Biomarkers and Therapeutic Target in Autoimmune Diseases?
Gianchecchi E; Delfino DV; Fierabracci A
Front Immunol; 2021; 12():616853. PubMed ID: 33679757
[TBL] [Abstract][Full Text] [Related]
3. Innate immunity as the trigger of systemic autoimmune diseases.
Saferding V; Blüml S
J Autoimmun; 2020 Jun; 110():102382. PubMed ID: 31883831
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory functions of TRPM7 and its implications in autoimmune diseases.
Liang HY; Chen Y; Wei X; Ma GG; Ding J; Lu C; Zhou RP; Hu W
Immunology; 2022 Jan; 165(1):3-21. PubMed ID: 34558663
[TBL] [Abstract][Full Text] [Related]
5. mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging.
Perl A
Ann N Y Acad Sci; 2015 Jun; 1346(1):33-44. PubMed ID: 25907074
[TBL] [Abstract][Full Text] [Related]
6. Advances of Regulatory B Cells in Autoimmune Diseases.
Zhu Q; Rui K; Wang S; Tian J
Front Immunol; 2021; 12():592914. PubMed ID: 33936028
[TBL] [Abstract][Full Text] [Related]
7. mTOR-dependent autophagy contributes to end-organ resistance and serves as target for treatment in autoimmune disease.
Perl A
EBioMedicine; 2018 Oct; 36():12-13. PubMed ID: 30262258
[No Abstract] [Full Text] [Related]
8. Type I Interferons in the Pathogenesis and Treatment of Autoimmune Diseases.
Jiang J; Zhao M; Chang C; Wu H; Lu Q
Clin Rev Allergy Immunol; 2020 Oct; 59(2):248-272. PubMed ID: 32557263
[TBL] [Abstract][Full Text] [Related]
9. Innate lymphoid cells in autoimmunity and chronic inflammatory diseases.
Xiong T; Turner JE
Semin Immunopathol; 2018 Jul; 40(4):393-406. PubMed ID: 29568972
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance and immunobiology of IL-21 in autoimmunity.
Long D; Chen Y; Wu H; Zhao M; Lu Q
J Autoimmun; 2019 May; 99():1-14. PubMed ID: 30773373
[TBL] [Abstract][Full Text] [Related]
11. mTOR signaling and metabolic regulation of T cells: new potential therapeutic targets in autoimmune diseases.
Pierdominici M; Vacirca D; Delunardo F; Ortona E
Curr Pharm Des; 2011 Dec; 17(35):3888-97. PubMed ID: 21933144
[TBL] [Abstract][Full Text] [Related]
12. Intestinal Microbes in Autoimmune and Inflammatory Disease.
Wu WH; Zegarra-Ruiz DF; Diehl GE
Front Immunol; 2020; 11():597966. PubMed ID: 33424846
[TBL] [Abstract][Full Text] [Related]
13. Alternative Splicing: A New Cause and Potential Therapeutic Target in Autoimmune Disease.
Ren P; Lu L; Cai S; Chen J; Lin W; Han F
Front Immunol; 2021; 12():713540. PubMed ID: 34484216
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic mTOR blockade in systemic autoimmunity: Implications for antiviral immunity and extension of lifespan.
Geier C; Perl A
Autoimmun Rev; 2021 Dec; 20(12):102984. PubMed ID: 34718162
[TBL] [Abstract][Full Text] [Related]
15. The pathogenicity of Th17 cells in autoimmune diseases.
Yasuda K; Takeuchi Y; Hirota K
Semin Immunopathol; 2019 May; 41(3):283-297. PubMed ID: 30891627
[TBL] [Abstract][Full Text] [Related]
16. Sirt1 ameliorates systemic sclerosis by targeting the mTOR pathway.
Zhu X; Chu H; Jiang S; Liu Q; Liu L; Xue Y; Zheng S; Wan W; Qiu J; Wang J; Zou H
J Dermatol Sci; 2017 Aug; 87(2):149-158. PubMed ID: 28532580
[TBL] [Abstract][Full Text] [Related]
17. miRNAs Alter T Helper 17 Cell Fate in the Pathogenesis of Autoimmune Diseases.
Huang J; Xu X; Yang J
Front Immunol; 2021; 12():593473. PubMed ID: 33968012
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic target of rapamycin (mTOR): a potential new therapeutic target for rheumatoid arthritis.
Zhang F; Cheng T; Zhang SX
Arthritis Res Ther; 2023 Oct; 25(1):187. PubMed ID: 37784141
[TBL] [Abstract][Full Text] [Related]
19. Metabolic regulation of pathogenic autoimmunity: therapeutic targeting.
Teng X; Cornaby C; Li W; Morel L
Curr Opin Immunol; 2019 Dec; 61():10-16. PubMed ID: 31422315
[TBL] [Abstract][Full Text] [Related]
20. B cell targeted therapies in autoimmune disease.
Barnas JL; Looney RJ; Anolik JH
Curr Opin Immunol; 2019 Dec; 61():92-99. PubMed ID: 31733607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
